Histopathological Features of Patients with Chronic Pancreatitis due to Mutations in the PRSS1 Gene: Evaluation of BRAF and KRAS2 Mutations
| Autor: | Orlin Belyaev, Ingo Stricker, Andrea Tannapfel, Jürgen Schnekenburger, Kerem Bulut, P. Felderbauer, Ansgar M. Chromik, Wolfgang Schmidt, Christophe A. Müller, Waldemar Uhl |
|---|---|
| Rok vydání: | 2008 |
| Předmět: | |
| Zdroj: | Digestion. 78:60-65 |
| ISSN: | 1421-9867 0012-2823 |
| DOI: | 10.1159/000165108 |
| Popis: | Background/Aims: Hereditary pancreatitis (HP) is a rare cause of chronic pancreatitis (CP; 1%) and more than 25 mutations in the PRSS1 gene have been detected. HP patients with the p.R122H mutation have a 35% lifetime risk of developing pancreatic cancer, but the oncogenetic process remains unknown. We have investigated the histopathological features and frequency of BRAF and KRAS2 mutations in 2 patients with PRSS1 mutations (p.A121T, p.R122H) and patients with CP (n = 11). Methods: Pancreatic tissue was stained with hematoxylin-eosin and examined by light microscopy. Mutational analysis of the BRAF (exon 5, 11) and KRAS2 (exon 1) genes was performed using PCR and direct DNA sequencing. Results: Histopathological features revealed similar results in both patients, pancreata showed strong fibrosis and ducts with signs of distortion, irregular size and noticeable dilatations. We identified one BRAF mutation (p.V600E) in the p.R122H patient and two KRAS2 (p.G12D; p.G12C) mutations in CP controls. Conclusions: Our results sustain the knowledge about the clinical phenotype of patients with PRSS1 mutations who have a high risk of pancreatic cancer. Whether the histopathological picture or the BRAF mutation is specific for patients with PRSS1 mutations or plays a specific role in the tumorigenesis of patients with HP needs to be further evaluated. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|